✦ LIBER ✦

The Bridging Concept: Optimizing Dose for Phase II/III in Alzheimer's Disease

✍ Scribed by Neal R. Cutler; John J. Sramek; John R. Kilborn

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of apoE genotyping as a pharmacogene

✍ Stone, David J.; Molony, Cliona; Potter, William Z. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB

A phase II double-blind, placebo-control

✍ Sabbagh, Marwan; Decourt, Boris; Liebsack, Carolyn; Sirrel, Sherye; Walker, Aaro 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 49 KB

2.277 OPTIMIZATION OF PHASE III STUDY DE

✍ R. Mills; D. Bahr; H. Williams 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 51 KB

A phase II study of the gamma-secretase

✍ Coric, Vlad; Salloway, Stephen; van Dyck, Christopher; Kerselaers, Wendy; Kaplit 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 56 KB

The phase shift index for marking functi

✍ Yin Xu; Guofan Xu; Gaohong Wu; Piero Antuono; Daniel B. Rowe; Shi-Jiang Li 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 683 KB

Imaging and cerebrospinal fluid biomarke

✍ Porsteinsson, Anton; Sperling, Reisa; Salloway, Stephen; Keren, Ron; van Dyck, C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 56 KB